VANGUARD GROUP INC - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$246,528,038
-23.3%
6,544,413
+0.2%
0.01%
-16.7%
Q1 2024$321,373,376
+45.9%
6,529,325
+8.2%
0.01%
+20.0%
Q4 2023$220,333,783
+93.6%
6,036,542
+22.6%
0.01%
+66.7%
Q3 2023$113,807,322
-11.5%
4,922,462
+0.4%
0.00%0.0%
Q2 2023$128,525,485
+13.3%
4,901,811
+11.2%
0.00%0.0%
Q1 2023$113,475,485
+0.9%
4,408,527
+2.0%
0.00%0.0%
Q4 2022$112,424,454
+23.3%
4,322,355
+35.2%
0.00%0.0%
Q3 2022$91,184,000
+35.0%
3,196,045
+16.5%
0.00%
+50.0%
Q2 2022$67,560,000
-58.5%
2,744,117
-4.8%
0.00%
-50.0%
Q1 2022$162,602,000
-8.3%
2,880,986
+0.7%
0.00%0.0%
Q4 2021$177,405,000
-2.3%
2,862,312
+0.0%
0.00%
-20.0%
Q3 2021$181,576,000
-18.6%
2,862,158
+5.8%
0.01%
-16.7%
Q2 2021$223,007,000
+21.5%
2,706,067
+8.5%
0.01%
+20.0%
Q1 2021$183,487,000
+99.0%
2,494,056
+96.2%
0.01%
+66.7%
Q4 2020$92,183,000
+183.5%
1,271,145
+86.4%
0.00%
+200.0%
Q3 2020$32,511,000
+43.0%
682,002
+26.0%
0.00%0.0%
Q2 2020$22,728,000
+86.1%
541,155
+19.6%
0.00%0.0%
Q1 2020$12,215,000
-18.5%
452,413
+16.1%
0.00%0.0%
Q4 2019$14,994,000
+887.7%
389,556
+456.5%
0.00%
Q3 2019$1,518,00070,0000.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 7,281,307$347,100,00032.35%
BVF INC/IL 2,053,991$97,914,0005.33%
Samsara BioCapital, LLC 398,017$18,973,0005.29%
Orbimed Advisors 7,406,307$353,059,0004.44%
Consonance Capital Management LP 602,732$28,732,0003.50%
Boxer Capital, LLC 2,075,905$98,958,0003.42%
Perceptive Advisors 3,481,148$165,946,0002.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,234,262$58,837,0001.43%
DRIEHAUS CAPITAL MANAGEMENT LLC 974,915$46,474,0000.95%
HighVista Strategies LLC 11,477$547,0000.40%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders